首页 | 官方网站   微博 | 高级检索  
     

丹参酮对肺纤维化大鼠的干预作用及其机制研究
引用本文:田淑霞 陈珺明 韩永龙 肖铁钢. 丹参酮对肺纤维化大鼠的干预作用及其机制研究[J]. 世界中医药, 2014, 9(12): 1647-1650
作者姓名:田淑霞 陈珺明 韩永龙 肖铁钢
作者单位:上海交通大学附属第六人民医院药剂科,上海200233
基金项目:上海市浦东新区中医学科人才培养项目资助项目(编号:PDZYXK-3-2013008)
摘    要:目的:观察丹参酮对博莱霉素致大鼠肺纤维化的影响及其作用机制。方法:SD大鼠随机分为5组:空白对照组、模型组、地塞米松阳性对照组、丹参酮组、丹参酮加地塞米松组。大鼠气管内注射博莱霉素复制肺纤维化模型后,各给药组腹腔注射相应药物,给药1次/d。28 d后处死动物,取固定部位肺组织分别行HE、Masson染色及电镜进行病理组织学检查;RT-PCR法检测丹参酮对大鼠肺组织中u PA、PAI-1 mRNA表达的影响。结果:与模型组相比,丹参酮组大鼠肺泡炎和肺纤维化程度明显减轻(P0.05,0.01);u PA显著升高而PAI-1表达明显降低(P0.05,0.01);在与地塞米松联合时以上作用更加明显。结论:丹参酮对博莱霉素所致大鼠肺纤维化具有一定的治疗作用且与地塞米松有协同作用,其机制可能与抑制炎性反应细胞的浸润活化、细胞外基质沉积及调控UPA及PAI-1之间平衡有关。

关 键 词:丹参酮  肺纤维化  UPA  PAI-1  博莱霉素
收稿时间:2014-04-15

Influence and Mechanism of Tanshinone on Bleomycin-Induced Pulmonary Fibrosis in Rats
Tian Shuxi,Chen Junming,Han Yonglong,Xiao Tiegang. Influence and Mechanism of Tanshinone on Bleomycin-Induced Pulmonary Fibrosis in Rats[J]. World Chinese Medicine, 2014, 9(12): 1647-1650
Authors:Tian Shuxi  Chen Junming  Han Yonglong  Xiao Tiegang
Affiliation:(Department of Pharmacy Service, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200233, China )
Abstract:Objective: To investigate the effect of Tanshinone on urokinase-type plasminogen activator( u PA) and urokinase-type plasminogen activator-1( PAI-1) in rats with pulmonary fibrosis and to explore the possible mechanism. Methods: Fifty Spague-Dawley rats were randomly divided into the control group,model group,Tanshinone group,dexamethasone groupand Tanshinone add dexamethasone group. The rats of model group and the treatment group were induced pulmonary fibrosis with bleomycin( 5 mg / kg) endotracheally,while the rats of other groups were given normal saline instead. After 28 days,rats with Tanshinone treatment by Intraperitoneal injection administration once a day were killed. The rat lung histopathology was examined with HE staining,masson staining and electron microscope. The influences of Tanshinone on the expression of u PA and PAI-1 mRNA in lung tissue of rats with Bleomycin-induced pulmonary fibrosis were assayed by RT-PCR. Results: Compared with the model group,the alveolitis and fibrosis extent were attenuated after Tanshinone treatment( P〈0. 05,0. 01),and the expression levels of u PA was increased and PAI-1 mRNA was decreased( P〈0. 05,0. 01)significantly. Compared with the dexamethasone group,therapeutic effect was more obviously when Tanshinone combine with dexamethasone( P〈0. 01). Conclusion: Tanshinone has a good action against experimental pulmonary fibrosis and has the synergetic effect with dexamethasone. The mechanisms might be related to the inhibition of activation of inflammatory cell infiltration,collagen deposition and regulation of equilibrium between the u PA and PAI-1.
Keywords:Tanshinone  Pulmonary fibrosis  uPA  PAI-1  Bleomycin
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号